Immune checkpoint inhibitors in the treatment of oesophageal squamous cell carcinoma: where are we and where are we going?

Oesophageal squamous cell carcinoma (ESCC) is a kind of malignant tumour with high invasiveness and a poor prognosis. Immunotherapy, especially immune checkpoint inhibitors (ICIs), is a rapidly growing therapeutic method that activates and enhances anti-tumour immunity to treat patients with maligna...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Ning, Xu, Xiaoling, Fan, Yun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10399266/
https://www.ncbi.nlm.nih.gov/pubmed/37547447
http://dx.doi.org/10.1177/17588359231189420

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10399266/
https://www.ncbi.nlm.nih.gov/pubmed/37547447
http://dx.doi.org/10.1177/17588359231189420

Ejemplares similares